Effect of Surgical Site Infections on Patient Reported Cosmetic Outcomes in Dermatologic Surgery
NCT ID: NCT04744961
Last Updated: 2021-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
114 participants
OBSERVATIONAL
2021-02-24
2021-05-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Split Scar Study to Assess Cosmetic Outcome From Differing Suture Spacing
NCT03284983
CO2 Laser Revision for Burn Related Donor Site Scars
NCT04456127
The Effect Of Light On Scar Appearance
NCT00544635
Comparison of Traditional Superficial Cutaneous Sutures Versus Steri-Strip Coaptive Film in Layered Dermatologic Closures
NCT01938586
Correlation of Early Postoperative Scar Appearance With Long-term Scar Outcomes
NCT04015453
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surgical site infections
SCAR-Q survey
Telephone survey
Normal would healing
SCAR-Q survey
Telephone survey
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SCAR-Q survey
Telephone survey
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Region Skane
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karim Saleh
Principal investigator, M.D, Ph.D
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of dermatology, Skåne university hospital
Lund, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RegionSkane2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.